KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
Portfolio Pulse from
Kahn Swick & Foti, LLC has announced a class action lawsuit against Kyverna Therapeutics, Inc. (KYTX) related to its February 2024 IPO. Investors with losses over $100,000 have until February 7, 2025, to file lead plaintiff applications.
December 21, 2024 | 4:00 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit related to its February 2024 IPO. Investors with significant losses are encouraged to apply as lead plaintiffs by February 7, 2025.
The class action lawsuit could negatively impact Kyverna's stock price as it may lead to financial liabilities and damage investor confidence. The deadline for lead plaintiff applications suggests ongoing legal proceedings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100